Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis

Seock Ah Im, Binghe Xu, Wei Li, Mark Robson, Quchang Ouyang, Dah Cherng Yeh, Hiroji Iwata, Yeon Hee Park, Joo Hyuk Sohn, Ling Ming Tseng, Carsten Goessl, Wenting Wu, Norikazu Masuda

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences